Publication | Closed Access

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

Ikzf1 DeletionsTumor BiologyChromatinHematological MalignancyMedicineMixed-phenotype Acute LeukemiaPathologyCancer GeneticsOncologyCell BiologyLong-term OutcomesCancer ResearchImatinib-based ChemotherapyMyeloid Neoplasia